BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in BriaCell Therapeutics Corp. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −2 vs. Q4 2021
- Shares held
- 3.30M
- +1.98M (+150.5%) vs. Q4 2021
- Total value
- $33.5M
- +$22.6M (+207.2%) vs. Q4 2021
- New holders
- 5
- 6 more added
- Sold out
- 7
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 32 | $0 | 0.00% | +20+166.7% | Added |
| GHP Investment Advisors, Inc. | 33 | $0 | 0.00% | +33 | New |
| UBS Group AG | 304 | $3.00K | 0.00% | −1,098−78.3% | Reduced |
| Koshinski Asset Management, Inc. | 500 | $5.07K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,406 | $35.0K | 0.00% | −1,139−25.1% | Reduced |
| Apollon Wealth Management, LLC | 13,900 | $141.0K | 0.01% | −9,000−39.3% | Reduced |
| Voloridge Investment Management, LLC | 15,161 | $154.0K | 0.00% | −188,205−92.5% | Reduced |
| Concord Wealth Partners | 16,775 | $170.0K | 0.04% | +4,000+31.3% | Added |
| Morgan Stanley | 20,258 | $206.0K | 0.00% | +11,961+144.2% | Added |
| Simplex Trading, LLC | 25,696 | $260.0K | 0.01% | +23,027+862.8% | Added |
| Sabby Management, LLC | 29,962 | $304.0K | 0.13% | +29,962 | New |
| Summit Trail Advisors, LLC | 35,000 | $355.0K | 0.03% | 00.0% | Unchanged |
| Redmond Asset Management, LLC | 137,942 | $1.40M | 0.42% | +844+0.6% | Added |
| National Bank of Canada | 156,900 | $1.59M | 0.01% | +127,000+424.7% | Added |
| Wasatch Advisors Inc | 244,691 | $2.48M | 0.01% | +244,691 | New |
| Leonard Green & Partners, L.P. | 500,000 | $5.07M | 0.06% | +500,000 | New |
| Lynwood Capital Management Inc. | 750,000 | $7.61M | 8.16% | −35,000−4.5% | Reduced |
| K.J. Harrison & Partners Inc | 1,351,782 | $13.7M | 2.21% | +1,351,782 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −24,977−100.0% | Sold out |
| Insight Advisors, LLC | 0 | $0 | 0.00% | −16,900−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −16,174−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −15,818−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −283−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −420−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −39−100.0% | Sold out |